Researching the implementation of over-the-counter oral contraceptives Grant

The Society of Family Planning is dedicated to advancing equitable access to contraception and abortion through science. The recent approval of Opill, the first over-the-counter oral contraceptive in the U.S., presents a unique opportunity to enhance contraceptive access. This initiative encourages research on implementation strategies to address cost, distribution, and education, ensuring the successful integration of over-the-counter contraceptives into healthcare options for all.

Purpose
The FDA’s landmark approval of Opill, the first over-the-counter daily oral contraceptive in the US, represents an unprecedented opportunity to significantly expand contraceptive access. To realize this potential, key partners—including advocates, payers, pharmacy benefit managers, policymakers, pharmacy systems, scholars, and state agencies—are actively working to address critical implementation issues, such as cost, distribution, and education. To accelerate learning and generate evidence that directly informs these efforts, the Society of Family Planning is offering the Researching the implementation of over-thecounter oral contraception funding opportunity. This opportunity seeks to fund research projects that produce actionable, evidence-based insights to guide implementation efforts related to over-the-counter daily oral contraceptives and advance equitable contraceptive access.